CommercialCoverageMedium impact
11.17.06u, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)
Independence Blue Cross·Urology·Medical Policy
Effective date
Jul 1, 2025
We identified it
Jun 19, 2026
Summary
Updated medical policy for surgical and minimally invasive treatments for urinary outlet obstruction due to benign prostatic hyperplasia (BPH) for commercial plans. This is a fresh policy update that may affect coverage criteria, prior authorization requirements, or billing procedures for BPH treatments.
Action Required
By July 1, 2025: Billing team must review the full policy details at the provided URL to understand specific changes to BPH treatment coverage and billing requirements. Update prior authorization workflows and billing procedures as needed for commercial plans. Notify urology providers of any new coverage criteria or documentation requirements.